Navigation Links
Cystic Fibrosis - Axentis Pharma Takes Over Patents and Continues Development of Innovative Platform Technology
Date:6/26/2008

ZURICH, Switzerland, June 26 /PRNewswire/ -- The rights to key patents for an innovative screening tool for treatments for cystic fibrosis were transferred today to Swiss biotech company Axentis Pharma AG. The company has acquired the rights from an Austrian firm that has made a vital contribution to the development of new approaches to treating the disease. The core element of the platform technology involves human proteins which - despite offering sufficient functionality - are subjected to enzymatic digestion in untreated cells due to genetic mutations in their structure.

Axentis Pharma AG (Switzerland) today announced that, as part of its takeover of an Austrian research company, it has also acquired two patent families that incorporate a series of international patent applications. The company is taking over these rights from Austrian-based BioDevelops Pharma GmbH, which three years ago identified the therapeutic potential offered by a new approach to the treatment of cystic fibrosis and secured the relevant rights.

The technology directly targets the functional cause of cystic fibrosis - the process whereby the body destroys mutated proteins which were originally designed to regulate the concentration of salt in the epithelial cells of the lungs and other organs. In patients with cystic fibrosis, a genetic defect means that many such proteins are produced with minor structural mutations. Although the mutated proteins still offer sufficient functionality, they are eliminated by quality control functions in the endoplasmic reticulum of the cells. The therapeutic approach now under development at Axentis Pharma enables these proteins - which are still functional despite their mutated structures - to escape enzymatic digestion.

Dr. Gergely Lukacs who guided the experimental set-up in his labs at the Sick Kids Hospital in Toronto explains: "In patients with cystic fibrosis, the protein CFTR (cystic fibrosis conductance regulator) with mu
'/>"/>

SOURCE Axentis Pharma AG
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Cystic Fibrosis Trial In Children Returns Positive Data
2. Study Confirms Anti-Infective ARIKACE(TM) Effectively Penetrates Mucus and Biofilm, and Kills Pseudomonas, a Bacteria Plaguing Cystic Fibrosis Patients
3. Genetic manipulation might model cystic fibrosis
4. Mpex Candidate, MP-376, Granted U.S. Orphan Drug Status for the Treatment of Cystic Fibrosis
5. Data show a decline in cystic fibrosis since introduction of prenatal carrier screening
6. Cystic Fibrosis: License Agreement Boosts Development of Therapy Against Lung Infections
7. PTC Therapeutics Announces Encouraging Additional Phase 2 Results of PTC124 in Cystic Fibrosis
8. GeneGo and the Cystic Fibrosis Foundation Collaborate to Advance Understanding of Cystic Fibrosis
9. BioMarin Licenses Technology From Leading Cystic Fibrosis Research Laboratory at the University of California, San Francisco
10. Coalition for Pulmonary Fibrosis and American Thoracic Society Continue Research Partnership Through 2010
11. Wyeth Pharmaceuticals Announces Organizational Change
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... SAN DIEGO and HONG KONG ... an innovative rare disease therapeutics enterprise, announced today that ... joined the company as vice president, research. Dr. McKew ... research, including key leadership positions at the National Institutes ... to its acquisition by Wyeth). Dr. McKew will lead aTyr,s ...
(Date:10/20/2014)... , Oct. 20, 2014 Asterias ... the Company has signed a Notice of Grant ... Medicine (CIRM), effective October 1, 2014.  The NGA ... payments and the release of additional grant funds ... grant award for clinical development of Asterias, product, ...
(Date:10/20/2014)... PureTech , a science and technology development ... today the closing of a $55 million growth ... a $120 Billion group of funds. The funding ... forward and to advance new healthcare related products ... really go for the big ideas that can ...
(Date:10/19/2014)... Latin American hardware encryption display market report defines and ... forecast of revenue. This market was valued at $165.0 ... million by 2018, at a CAGR of 70.3% from ... the Latin American hardware encryption market report to get ... provides a glimpse of the segmentation of the market, ...
Breaking Biology Technology:aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 2aTyr Pharma Appoints John C. McKew, Ph.D., as Vice President, Research 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 2Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 3Asterias Biotherapeutics Announces Notice of Grant Award with CIRM for Phase 1/2a Clinical Trial of AST-OPC1 in Complete Cervical Spinal Cord Injury 4PureTech Announces Expansion with Oversubscribed $55M Funding Round 2PureTech Announces Expansion with Oversubscribed $55M Funding Round 3PureTech Announces Expansion with Oversubscribed $55M Funding Round 4PureTech Announces Expansion with Oversubscribed $55M Funding Round 5PureTech Announces Expansion with Oversubscribed $55M Funding Round 6The Latin American hardware encryption display market is expected to reach $2,366.8 million by 2018 - New Report by MicroMarket Monitor 2The Latin American hardware encryption display market is expected to reach $2,366.8 million by 2018 - New Report by MicroMarket Monitor 3
... 2012   Led by NUMODA CAPITAL INNOVATIONS, LLC., PINNACLE BIOLOGICS announced ... in a combination of Equity, and Debt Conversion. ... for Pinnacle Biologics. After completing the acquisition of ... Aptalis Pharma early last year, Pinnacle continues the ...
... Jan. 9, 2012 Exagen Diagnostics, Inc., ... and markets proprietary tests for rheumatologists and gastroenterologists, announced ... the diagnosis of lupus (Systemic Lupus Erythematosus). ... SLE and Rule-Out other rheumatic diseases to help establish ...
... Jan. 9, 2012 Chembio Diagnostics, Inc. (OTC.PK: ... and licenses point-of-care diagnostic tests, today announced that Lawrence ... at the Biotech Showcase in San Francisco at approximately ... Wednesday, January 11, 2012.   The conference ...
Cached Biology Technology:Pinnacle Biologics, Inc. Announces the Successful Completion of a Financing Round 2Pinnacle Biologics, Inc. Announces the Successful Completion of a Financing Round 3Exagen Diagnostics Launches Cutting-Edge Lupus Diagnostic 2Chembio Presenting at Biotech Conference 2Chembio Presenting at Biotech Conference 3
(Date:10/15/2014)... 44th Rosenstiel Award for Distinguished Work in Biomedical Science ... mechanisms of genomic instability and its implications for the ... alumnus to win the Rosenstiel Award; the first, Rod ... is the Charles A. Janeway Professor of Pediatrics and ... investigator at the Howard Hughes Medical Institute at Boston ...
(Date:10/14/2014)... A new study published in Cancer Research ... liver and colon cancers—can promote the development of skin ... proliferation and survival of sun-damaged skin cells. , Previously ... seven proteins called sirtuins that help regulate genomic stability ... aging. SIRT6 helps repair DNA damage, which can lead ...
(Date:10/14/2014)... is how to produce enough food to feed the ... Agriculture Organization of the United Nations predicts that food ... to feed a growing global population, and plants are ... production. Plants—grains, cereals, fruits, vegetables, and more—feed humans ... must tap into our knowledge of how plants work ...
Breaking Biology News(10 mins):Brandeis awards 44th Rosenstiel Award to pioneering geneticist Fred Alt 2Two-faced gene: SIRT6 prevents some cancers but promotes sun-induced skin cancer 2Building a bridge from basic botany to applied agriculture 2Building a bridge from basic botany to applied agriculture 3
... MANHATTAN, Kan. -- What if you could shut down ... How about hacking a pacemaker and reprogramming it to ... scenes from an espionage film, they are also some ... experts are working to prevent. Eugene Vasserman, assistant ...
... cucumbers and other crops susceptible to infection by downy ... production costs thanks to collaborative research by Clemson University,s ... North Carolina State University. Anthony P. Keinath, professor ... Center in Charleston, recently was awarded a $40,000 USDA ...
... elk,s personality type is a big factor in whether or ... GPS collars on more than 100 male and female elk ... population could be divided into two categories: bold runners and ... moved quickly through the study area and preferred to graze ...
Cached Biology News:Internal relations 2Internal relations 3Internal relations 4Clemson plant pathologist working to raise cucurbit yields, lower production costs 2In elk hunting, success depends on the animal's personality 2
Image Acquisition and documentation system for fluorescent and non-fluorescent gels, membranes, blots, film, plates and assays...
... features a 4.1 mega pixel digital color ... TLC color images., The cabinet features ... longwave UV tubes positioned on two sides ... fluorescence studies , Interior overhead white ...
Rabbit Polyclonal antibody to Perilipin Applications: This antibody is useful for Western blot anlaysis where a band at ~60 kDa is seen....
... thermoactive designer enzyme that enables RT-PCR ... PCR enzyme allows reverse transcription and ... elevated temperatures (65C), which helps to ... and results in highly stringent, accurate ...
Biology Products: